Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases
It has now been established that psychosocial risk factors significantly worsen the course of cardiovascular diseases (CVDs) and reduce patients’ adherence to treatment. Patients with CVDs are characterized by a high prevalence of anxiety comorbidities, which can reach 50-60%. The presence of concom...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2022-06-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3280 |
| _version_ | 1797882361698844672 |
|---|---|
| author | O. M. Drapkina A. I. Fedin O. A. Dorofeeva V. E. Medvedev E. N. Kareva O. N. Dzhioeva S. G. Kuklin Е. Yu. Solovieva D. I. Abdulganieva Z. F. Kim M. S. Grigorovich I. I. Shaposhnik N. А. Koryagina S. B. Seredenin |
| author_facet | O. M. Drapkina A. I. Fedin O. A. Dorofeeva V. E. Medvedev E. N. Kareva O. N. Dzhioeva S. G. Kuklin Е. Yu. Solovieva D. I. Abdulganieva Z. F. Kim M. S. Grigorovich I. I. Shaposhnik N. А. Koryagina S. B. Seredenin |
| author_sort | O. M. Drapkina |
| collection | DOAJ |
| description | It has now been established that psychosocial risk factors significantly worsen the course of cardiovascular diseases (CVDs) and reduce patients’ adherence to treatment. Patients with CVDs are characterized by a high prevalence of anxiety comorbidities, which can reach 50-60%. The presence of concomitant anxiety disorders seriously worsens the prognosis of CVDs. The results of studies showed that anxiety increases the risk of fatal myocardial infarction and sudden death by 1,9 times and 4,5 times, respectively. Therefore, the correction of psychosocial factors, in particular anxiety symptoms, should be an important component of the treatment of patients with CVDs. The conducted studies show that the use of fabomotizole in patients with CVD and concomitant anxiety disorders reduces the anxiety manifestations. In addition, a pronounced improvement of somatic status is recorded, which is important for improving the course and prognosis of CVDs. The accumulated experience of fabomotizole use makes it possible to recommend it for the treatment of patients with anxiety and CVDs. |
| first_indexed | 2024-04-10T03:33:31Z |
| format | Article |
| id | doaj.art-e28d4961210f4176aac6b269c8a07b8a |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2024-04-10T03:33:31Z |
| publishDate | 2022-06-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-e28d4961210f4176aac6b269c8a07b8a2023-03-13T07:23:32Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252022-06-0121510.15829/1728-8800-2022-32802465Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseasesO. M. Drapkina0A. I. Fedin1O. A. Dorofeeva2V. E. Medvedev3E. N. Kareva4O. N. Dzhioeva5S. G. Kuklin6Е. Yu. Solovieva7D. I. Abdulganieva8Z. F. Kim9M. S. Grigorovich10I. I. Shaposhnik11N. А. Koryagina12S. B. Seredenin13ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава РоссииФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РоссииФБГНУ НИИ фармакологии им. В.В. ЗакусоваМедицинский институт ФГАОУ ВО РУДНФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Сеченовский Университет)ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава России; ФГБОУ ВО Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава РоссииИГМАПО филиал ФГБОУ ДПО РМАНПО Минздрава РоссииФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РоссииФГБОУ ВО Казанский государственный медицинский университет Минздрава РоссииФГБОУ ВО Казанский государственный медицинский университет Минздрава РоссииФГБОУ ВО Кировский государственный медицинский университет Минздрава РоссииФГБОУ ВО Южно-Уральский государственный медицинский университет Минздрава РоссииФГБОУ ВО ПГМУ им. акад. Е.А. Вагнера Минздрава РоссииФБГНУ НИИ фармакологии им. В. В. ЗакусоваIt has now been established that psychosocial risk factors significantly worsen the course of cardiovascular diseases (CVDs) and reduce patients’ adherence to treatment. Patients with CVDs are characterized by a high prevalence of anxiety comorbidities, which can reach 50-60%. The presence of concomitant anxiety disorders seriously worsens the prognosis of CVDs. The results of studies showed that anxiety increases the risk of fatal myocardial infarction and sudden death by 1,9 times and 4,5 times, respectively. Therefore, the correction of psychosocial factors, in particular anxiety symptoms, should be an important component of the treatment of patients with CVDs. The conducted studies show that the use of fabomotizole in patients with CVD and concomitant anxiety disorders reduces the anxiety manifestations. In addition, a pronounced improvement of somatic status is recorded, which is important for improving the course and prognosis of CVDs. The accumulated experience of fabomotizole use makes it possible to recommend it for the treatment of patients with anxiety and CVDs.https://cardiovascular.elpub.ru/jour/article/view/3280сердечно-сосудистые заболеваниятревогапациенткоморбидностьфабомотизолафобазол |
| spellingShingle | O. M. Drapkina A. I. Fedin O. A. Dorofeeva V. E. Medvedev E. N. Kareva O. N. Dzhioeva S. G. Kuklin Е. Yu. Solovieva D. I. Abdulganieva Z. F. Kim M. S. Grigorovich I. I. Shaposhnik N. А. Koryagina S. B. Seredenin Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases Кардиоваскулярная терапия и профилактика сердечно-сосудистые заболевания тревога пациент коморбидность фабомотизол афобазол |
| title | Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases |
| title_full | Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases |
| title_fullStr | Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases |
| title_full_unstemmed | Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases |
| title_short | Influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases |
| title_sort | influence of psychosocial risk factors on the course and prognosis of cardiovascular diseases |
| topic | сердечно-сосудистые заболевания тревога пациент коморбидность фабомотизол афобазол |
| url | https://cardiovascular.elpub.ru/jour/article/view/3280 |
| work_keys_str_mv | AT omdrapkina influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT aifedin influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT oadorofeeva influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT vemedvedev influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT enkareva influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT ondzhioeva influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT sgkuklin influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT eyusolovieva influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT diabdulganieva influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT zfkim influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT msgrigorovich influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT iishaposhnik influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT nakoryagina influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases AT sbseredenin influenceofpsychosocialriskfactorsonthecourseandprognosisofcardiovasculardiseases |